|
Delayed
Toronto S.E.
11:08:42 01/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.4800 CAD | +2.13% |
|
-2.04% | +5.49% |
| 27/08 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 20/08 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
 | 1.52Cr | -7.09% | - | - | - | -6.35x | |
| 1.05TCr | 7.32% | 5.37% | 9.32% | 7.03% | -7.43x | |
| 702.77Cr | 4.99% | 7.6% | 10.5% | 12.24% | -1.07x | |
| 496.64Cr | 5.65% | 5.36% | 11.33% | 8.75% | -5.22x | |
| 349.32Cr | 6.87% | 10.04% | 14.98% | 6.06% | -1.29x | |
| 272.25Cr | 8.14% | 9.08% | 30.3% | 12.4% | 0.71x | |
| 393.2Cr | 4.49% | 7.41% | 17.16% | 4.67% | -0.84x | |
| 270.7Cr | 6.77% | 9.78% | 49.2% | 14.9% | -0.5x | |
| 733.86Cr | 3.55% | 6.24% | 17.17% | - | -0.31x | |
| 144.87Cr | 3.4% | 5.02% | - | - | - | |
| 269.26Cr | 2.29% | 4.33% | 17.95% | 4.87% | 1.97x | |
| 345.3Cr | -1.28% | -0.41% | -7.99% | -3.4% | 5.65x | |
| 247.86Cr | 1.52% | 2.44% | 3.57% | 3.39% | -1.3x | |
| 179.62Cr | 4.78% | 6.95% | 23.35% | 6.29% | 2.51x | |
| 74Cr | 3.19% | 4.71% | 11.82% | - | -1.01x | |
| 78Cr | 3.17% | 4.21% | 31.35% | - | 0.65x | |
| Average | 350.57Cr | 3.61% | 5.87% | 17.14% | 7.02% | -0.92x | |
| Weighted average by Cap. | 595.82Cr | 5.6% | 6.38% | 15.02% | 8.12% | -2.93x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
